Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Micafungin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 12 USDMF, 5 JDMF, 4 EU WC, 7 KDMF, 11 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 30 FDA Orange Book, 57 Europe, 8 Canada, 6 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - EQ 100MG BASE/VIAL, INJECTABLE;INTRAVENOUS - EQ 50MG BASE/VIAL, SOLUTION;INTRAVENOUS - EQ 100MG BASE/100ML (EQ 1MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 150MG BASE/150ML (EQ 1MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 50MG BASE/50ML (EQ 1MG BASE/ML)

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 20 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 7 Health Canada Patents

$ Xls

Filters

SOLUTION;INTRAVENOUS - EQ 100MG BASE/100ML (EQ 1MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 150MG BASE/150ML (EQ 1MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 50MG BASE/50ML (EQ 1MG BASE/ML)

INJECTABLE;INTRAVENOUS - EQ 100MG BASE/VIAL

INJECTABLE;INTRAVENOUS - EQ 50MG BASE/VIAL

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Micafungin

Micafungin

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers

12 USDMF

5 JDMF

4 EU WC

7 KDMF

11 NDC API

24 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers

30 FDA Orange Book

57 Europe

8 Canada

6 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - EQ 100MG BASE/VIAL

INJECTABLE;INTRAVENOUS - EQ 50MG BASE/VIAL

SOLUTION;INTRAVENOUS - EQ 100MG BASE/100ML (EQ 1MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 150MG BASE/150ML (EQ 1MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 50MG BASE/50ML (EQ 1MG BASE/ML)

DIGITAL CONTENT

3 Data Compilation #PharmaFlow

20 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions

2 Regulatory FDF Prices

8 Annual Reports

MARKET PLACE

10 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents

7 Health Canada Patents

Filters